↓ Skip to main content

microRNA: Medical Evidence

Overview of attention for book
Attention for Chapter 6: microRNAs and Neurodegenerative Diseases.
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
5 X users

Readers on

mendeley
78 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
microRNAs and Neurodegenerative Diseases.
Chapter number 6
Book title
microRNA: Medical Evidence
Published in
Advances in experimental medicine and biology, January 2015
DOI 10.1007/978-3-319-22671-2_6
Pubmed ID
Book ISBNs
978-3-31-922670-5, 978-3-31-922671-2
Authors

Qiu, Lifeng, Tan, Eng King, Zeng, Li, Lifeng Qiu, Eng King Tan, Li Zeng

Editors

Gaetano Santulli

Abstract

microRNAs (miRNAs) are small, noncoding RNA molecules that through imperfect base-pairing with complementary sequences of target mRNA molecules, typically cleave target mRNA, causing subsequent degradation or translation inhibition. Although an increasing number of studies have identified misregulated miRNAs in the neurodegenerative diseases (NDDs) Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis, which suggests that alterations in the miRNA regulatory pathway could contribute to disease pathogenesis, the molecular mechanisms underlying the pathological implications of misregulated miRNA expression and the regulation of the key genes involved in NDDs remain largely unknown. In this chapter, we provide evidence of the function and regulation of miRNAs and their association with the neurological events in NDDs. This will help improve our understanding of how miRNAs govern the biological functions of key pathogenic genes in these diseases, which potentially regulate several pathways involved in the progression of neurodegeneration. Additionally, given the growing interest in the therapeutic potential of miRNAs, we discuss current clinical challenges to developing miRNA-based therapeutics for NDDs.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 78 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 18%
Student > Bachelor 13 17%
Student > Master 12 15%
Researcher 6 8%
Professor > Associate Professor 4 5%
Other 10 13%
Unknown 19 24%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 12 15%
Medicine and Dentistry 11 14%
Neuroscience 10 13%
Agricultural and Biological Sciences 7 9%
Pharmacology, Toxicology and Pharmaceutical Science 7 9%
Other 11 14%
Unknown 20 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 September 2021.
All research outputs
#1,787,637
of 22,835,198 outputs
Outputs from Advances in experimental medicine and biology
#238
of 4,951 outputs
Outputs of similar age
#26,497
of 353,198 outputs
Outputs of similar age from Advances in experimental medicine and biology
#14
of 272 outputs
Altmetric has tracked 22,835,198 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,951 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,198 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 272 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.